Tenderwize
Retour à la recherche

Open house pharmaceutical discount agreements for active substance Biperiden, ATC N04AA02

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 163 days left·Open·Supplies
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Biperiden, ATC N04AA02

45/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

45 / 100

Complexité

30 / 100

Facteurs de risque

The buyer reserves the right to replace open-house agreements with exclusive discount contracts, which would automatica...

No estimated volume or value; discount rates are not specified but must be agreed upon. The actual profitability depend...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Mar 31, 2027

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of authorized and marketable pharmaceutical products containing Biperiden (ATC N04AA02).
  • Agreement to offer discount on the drug's price as per SGB V §§130a(8)/130c(1).
Afficher le résumé complet

This is an open-house model for non-exclusive pharmaceutical discount agreements on the active substance Biperiden (ATC N04AA02) with AOK Rheinland-Pfalz/Saarland. The contract is not a public procurement under EU directives but published voluntarily for transparency. The procedure allows any interested pharmaceutical company to enter into a standard agreement at any time during a 24-month window (June 2025 – May 2027), with uniform conditions. No estimated value is provided. The buyer reserves the right to replace these agreements with exclusive ones through separate tenders, which would automatically terminate open-house contracts.

Risques

The buyer reserves the right to replace open-house agreements with exclusive discount contracts, which would automatica...

No estimated volume or value; discount rates are not specified but must be agreed upon. The actual profitability depend...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Products must be authorized and marketable in Germany (verified via Lauer-Taxe or AMIce database).

Administrative

  • Submission of signed contract documents and supporting evidence of drug authorization/marketability.
  • No electronic submission allowed; documents must be submitted in original.

Acheteur

Localisation

Eisenberg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE271900642

Activité

Health

Lots (1)

LOT-0001

Open house pharmaceutical discount agreements for active substance Biperiden, ATC N04AA02

Non-exclusive discount agreements for Biperiden products. All interested pharmaceutical companies can join under uniform terms. Maximum contract duration 24 months. First possible start date: 01.06.2025. Contracts can be terminated by the buyer early if exclusive agreements are concluded.

SuppliesEU fundedElectronic submission

Localisation

Eisenberg, Germany

Durée

May 2025 - May 2027

Catégorie

Pharmaceutical products

Détails de la procédure

Date de publication
10 Apr 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
235451-2025

Documents (1)

Appels d'offres similaires